OTCMKTS:HBPCF Helix BioPharma (HBPCF) Stock Price, News & Analysis → Incredible Opportunity to Retire FAST! (From Crypto 101 Media) (Ad) Free HBPCF Stock Alerts $0.14 0.00 (0.00%) (As of 04/22/2024 ET) Add Compare Share Share Today's Range$0.14▼$0.1450-Day Range$0.14▼$0.1552-Week Range$0.14▼$0.15VolumeN/AAverage Volume14 shsMarket Capitalization$31.59 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsShort InterestStock AnalysisChartEarningsShort Interest Get Helix BioPharma alerts: Email Address Ad Crypto 101 MediaIncredible Opportunity to Retire FAST!A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide About Helix BioPharma Stock (OTCMKTS:HBPCF)Helix BioPharma Corp. operates as an immune-oncology company in Canada. It is developing L-DOS47 for the treatment of non-small cell lung cancer; and V-DOS47 that targets the vascular epithelial growth factor receptor 2. Helix BioPharma Corp. has collaboration agreements with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with University Hospital Tuebingen to assess the therapeutic response of L-DOS47 in cancer models expressing CEACAM6, with advanced preclinical metabolic imaging. The company is headquartered in Toronto, Canada.Read More HBPCF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HBPCF Stock News HeadlinesApril 17, 2024 | cnet.comHelix Dusk Luxe Mattress Review 2024: A Comfortable Pillow-Top BedJanuary 22, 2024 | finance.yahoo.comHelix BioPharma Corp. Reports Voting ResultsApril 23, 2024 | Crypto 101 Media (Ad)Incredible Opportunity to Retire FAST!A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.December 14, 2023 | finance.yahoo.comHelix BioPharma Corp. Announces Fiscal 2024 First Quarter ResultsNovember 28, 2023 | morningstar.comHelix BioPharma Corp HBPOctober 27, 2023 | msn.comHelix Biopharma GAAP EPS of -C$0.03October 27, 2023 | finance.yahoo.comHelix BioPharma Corp. Announces Fiscal 2023 Year-End ResultsSeptember 14, 2023 | uk.investing.comHelix BioPharma Corp. (HBP)April 23, 2024 | Crypto 101 Media (Ad)Incredible Opportunity to Retire FAST!A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.June 29, 2023 | finance.yahoo.comHELIX BIOPHARMA CORP (HBPCF) stock forecast and price targetMay 14, 2023 | thestreet.comHelix Energy Up on BP Spill ContractMarch 15, 2023 | finance.yahoo.comHelix Biopharma Corp. Announces Fiscal 2023 Second Quarter ResultsJanuary 31, 2023 | finance.yahoo.comIs Helix BioPharma (TSE:HBP) In A Good Position To Deliver On Growth Plans?September 3, 2022 | seekingalpha.comHelix BioPharma appoints R&D headSeptember 2, 2022 | benzinga.comProactive news headlines including Shell, Maverix Metals, Helix BioPharma, Wellteq Digital Health and Trees CorpMay 18, 2022 | finance.yahoo.comHelix Biopharma Corp. Announces Appointment of New Chief Financial OfficerApril 18, 2022 | ca.proactiveinvestors.comHelix BioPharma appoints Artur Gabor as its new CEO; adds three new board membersApril 13, 2022 | finance.yahoo.comHelix Biopharma Corp. Announces Extension of Early Warrant Exercise Incentive Program and Receipt of Private Placement SubscriptionApril 13, 2022 | finance.yahoo.comHelix Biopharma Corp. Announces Extension of Early Warrant Exercise Incentive Program and Receipt of Private Placement SubscriptionMarch 18, 2022 | seekingalpha.comHelix Biopharma GAAP EPS of -$0.01March 16, 2022 | finance.yahoo.comHelix Biopharma Corp. Announces Unexpected Passing of Interim CEO and Chairman of the BoardJanuary 28, 2022 | nasdaq.comHelix Biopharma Corp. (HBPCF)January 28, 2022 | finance.yahoo.comHelix BioPharma Corp. Reports Voting Results and Appointment of New Board DirectorDecember 9, 2021 | finance.yahoo.comHelix Biopharma Corp. Announces Fiscal 2021 Year-End ResultsNovember 30, 2021 | finance.yahoo.comHelix BioPharma Corp. Provides Third Bi-Weekly MCTO Status UpdateOctober 15, 2021 | finance.yahoo.comHelix BioPharma Corp. Announces Delay of Annual FilingsOctober 15, 2021 | finance.yahoo.comHelix BioPharma Corp. Announces Delay of Annual FilingsSee More Headlines Receive HBPCF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Helix BioPharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/23/2024Next Earnings (Estimated)6/12/2024Fiscal Year End7/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolOTCMKTS:HBPCF CUSIPN/A CIKN/A Webwww.helixbiopharma.com Phone905-841-2300Fax905-841-2244Employees9Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-4,690,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-817.64% Return on Assets-308.71% Debt Debt-to-Equity RatioN/A Current Ratio1.46 Quick Ratio1.46 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares229,440,000Free Float212,003,000Market Cap$31.59 million OptionableNot Optionable Beta-0.10 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. Jacek AntasChairman & CEOMr. Praveen Kumar Varshney F.C.A. (Age 58)FCA, FCPA, LLB, CFO & Corporate Secretary Dr. Gabrielle M. Siegers M.A.Ph.D., Head of R&DDr. Srikanth SolaChief Strategy OfficerDr. Christof BoehlerChief Business Development OfficerKey CompetitorsJanOneNASDAQ:JANVYNE TherapeuticsNASDAQ:VYNENRx PharmaceuticalsNASDAQ:NRXPPalatin TechnologiesNYSEAMERICAN:PTNAprea TherapeuticsNASDAQ:APREView All Competitors HBPCF Stock Analysis - Frequently Asked Questions How have HBPCF shares performed in 2024? Helix BioPharma's stock was trading at $0.1450 at the beginning of the year. Since then, HBPCF shares have decreased by 5.0% and is now trading at $0.1377. View the best growth stocks for 2024 here. When is Helix BioPharma's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, June 12th 2024. View our HBPCF earnings forecast. How do I buy shares of Helix BioPharma? Shares of HBPCF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:HBPCF) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Reporttop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThe #1 Crypto for 2024InvestorPlaceGreat Crypto BullWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Helix BioPharma Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
